Patient Access

Trend Analysis: Medicaid Work Requirements
Public Policy Trend Analysis: Medicaid Work Requirements

Millions of low-income Americans are on the verge of a precarious new reality where maintaining essential health insurance is contingent not on a willingness to work, but on navigating the often-insurmountable barriers of personal illness and family caregiving. This policy shift represents a

How Can Mobile EPRs Transform Remote Healthcare?
Data and Information How Can Mobile EPRs Transform Remote Healthcare?

Delivering consistent, high-quality healthcare across geographically challenging and sparsely populated regions presents a unique set of obstacles, where intermittent connectivity and reliance on cumbersome paper-based systems can create significant barriers to effective patient management. For

Is the Affordable Care Act No Longer Affordable?
Business Is the Affordable Care Act No Longer Affordable?

The Affordable Care Act has entered its most turbulent period to date, as the expiration of enhanced federal subsidies at the close of 2025 has triggered a significant affordability crisis for millions of Americans seeking coverage in 2026. This abrupt shift has dramatically increased monthly

Can One Startup Fix Your Healthcare Nightmare?
Business Can One Startup Fix Your Healthcare Nightmare?

With extensive experience in medical device manufacturing and a keen eye for innovation in health-tech, Faisal Zain has a unique perspective on the forces shaping the future of healthcare. We sat down with him to discuss the recent rise of care navigation platforms, particularly Solace Health,

The High Cost of Propping Up Bad Telehealth
Technology The High Cost of Propping Up Bad Telehealth

A recurring scene plays out in healthcare leadership meetings across the country where technology teams present glowing reports of their telehealth system's success, citing the intensive, hands-on support provided to clinicians and patients as a key achievement. This narrative of

Eli Lilly Acquires Orna in a $2.4B Cell Therapy Deal
Business Eli Lilly Acquires Orna in a $2.4B Cell Therapy Deal

The multi-billion-dollar price tag attached to a pharmaceutical acquisition often captures headlines, but the true significance of Eli Lilly's $2.4 billion deal for Orna Therapeutics lies in the revolutionary science it aims to command. This is not merely a financial transaction; it represents

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later